Intuniv is only the second non-stimulant treatment for the condition, following Lilly's off-patent drug Strattera. Perry Sternberg, senior vice president, Neuroscience Business Unit, Shire said ...

The Centers for Medicare and Medicaid Services (CMS) just shared a preliminary list of generic drugs it plans to make available to Medicare recipients for $2 in a pilot program. The program ...

A non-stimulant drug may be a better option for someone who has side effects from stimulant drugs ... It is a liquid taken by ...

Any Australian who has filled a prescription at the chemist will have been asked if they want a branded product or the generic version. And with consumers looking to cut costs wherever they can ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Drug-resistant infections occur when pathogens change in ways that render antimicrobial drugs ineffective. As a result, the pathogens survive and continue to spread. When infections are treatable with ...

Our solutions cater to either of the two issues. In this article, we are going to see how to fix the Generic PnP Monitor driver issue on Windows 11/10. What is a Generic PnP Monitor driver?

But a generic version (and the active ingredient) of this popular medication, sildenafil, is widely available from several drug manufacturers at a fraction of the cost. Read on to find out more ...

Another colleague sees the agony in your face and offers to help. She offers you her generic acetaminophen bottle, and a part of you panics, thinking it might not be as effective as your cherished ...

For one reason or the other, the USB ports may stop working on your Windows 11 or Windows 10 computer, and you may notice that the Generic USB Hub device is missing or not showing in Device ...

The average drug now costs more than US$1 billion to develop and takes more than a decade to reach the market 1. And for every success, there are nine drug candidates that fail clinical trials 2.

Antibody–drug conjugates have emerged as a powerful tool to deliver highly targeted cancer therapies. Next-generation antibody-drug conjugate designs aim to push the envelope even further.